# Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

> **NCT02258880** · PHASE2 · WITHDRAWN · sponsor: **Daiichi Sankyo**

## Conditions studied

- Stroke

## Interventions

- **DRUG:** SUN13837
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02258880
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study was stopped for business/administrative reasons and not for patient safety concerns
- **Last updated:** 2015-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02258880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02258880, "Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02258880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*